134 related articles for article (PubMed ID: 15554555)
1. P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women.
Agorastos T; Masouridou S; Lambropoulos AF; Chrisafi S; Miliaras D; Pantazis K; Constantinides TC; Kotsis A; Bontis I
Eur J Cancer Prev; 2004 Aug; 13(4):277-80. PubMed ID: 15554555
[TBL] [Abstract][Full Text] [Related]
2. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women.
Agorastos T; Lambropoulos AF; Constantinidis TC; Kotsis A; Bontis JN
Eur J Cancer Prev; 2000 Apr; 9(2):113-8. PubMed ID: 10830578
[TBL] [Abstract][Full Text] [Related]
3. [Association of p53 gene polymorphism with susceptibility to ovarian cancer].
Kang S; Duan LH; Zhang JH; Guo W; Wang N; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):754-8. PubMed ID: 15634502
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma.
Peller S; Halperin R; Schneider D; Kopilova Y; Rotter V
Oncol Rep; 1999; 6(1):193-7. PubMed ID: 9864427
[TBL] [Abstract][Full Text] [Related]
6. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.
Høgdall EV; Høgdall CK; Christensen L; Glud E; Blaakaer J; Bock JE; Vuust J; Nørgaard-Pedersen B; Kjaer SK
Anticancer Res; 2002; 22(3):1859-64. PubMed ID: 12168882
[TBL] [Abstract][Full Text] [Related]
7. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of codon 72 of the TP53 gene in endometrial carcinoma of postmenopausal women.
Zając A; Stachowiak G; Smolarz B; Wilczyński JR
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1312-8. PubMed ID: 24379271
[TBL] [Abstract][Full Text] [Related]
9. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.
Katiyar S; Thelma BK; Murthy NS; Hedau S; Jain N; Gopalkrishna V; Husain SA; Das BC
Mol Cell Biochem; 2003 Oct; 252(1-2):117-24. PubMed ID: 14577584
[TBL] [Abstract][Full Text] [Related]
11. The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian women.
Zubor P; Stanclova A; Kajo K; Hatok J; Klobusiakova D; Visnovsky J; Danko J
Oncology; 2009; 76(3):173-83. PubMed ID: 19209008
[TBL] [Abstract][Full Text] [Related]
12. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
13. The Association Between p53 Codon 72 Polymorphism and Endometrial Cancer Risk: A System Review and Meta-analysis.
Yi K; Yang L; Lan Z; Xi M
Int J Gynecol Cancer; 2016 Jul; 26(6):1121-8. PubMed ID: 27327151
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer.
Nunobiki O; Ueda M; Yamamoto M; Toji E; Sato N; Izuma S; Okamoto Y; Torii K; Noda S
Hum Cell; 2009 Nov; 22(4):101-6. PubMed ID: 19874399
[TBL] [Abstract][Full Text] [Related]
15. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation.
Makni H; Franco EL; Kaiano J; Villa LL; Labrecque S; Dudley R; Storey A; Matlashewski G
Int J Cancer; 2000 Aug; 87(4):528-33. PubMed ID: 10918193
[TBL] [Abstract][Full Text] [Related]
16. The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.
Assoumou SZ; Boumba AL; Ndjoyi-Mbiguino A; Khattabi A; Ennaji MM
Med Oncol; 2015 Jan; 32(1):281. PubMed ID: 25502079
[TBL] [Abstract][Full Text] [Related]
17. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients.
Morari EC; Lima AB; Bufalo NE; Leite JL; Granja F; Ward LS
J Cancer Res Clin Oncol; 2006 Aug; 132(8):521-8. PubMed ID: 16788846
[TBL] [Abstract][Full Text] [Related]
18. The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study.
Jo H; Kang S; Kim SI; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP
Gynecol Obstet Invest; 2007; 64(2):84-8. PubMed ID: 17314486
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A
Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853
[TBL] [Abstract][Full Text] [Related]
20. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
Nagpal JK; Sahni S; Das BR
Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
